Elanco has a total of 4262 patents globally, out of which 2134 have been granted. Of these 4262 patents, more than 64% patents are active. United States of America is where Elanco has filed the maximum number of patents, followed by Australia and Canada. Parallelly, Germany seems to be the main focused R&D centre and also United States is the origin country of Elanco.
Elanco was founded in the year 1954. The Company operates as an animal health care company. The Company develops, manufactures and markets products for companion and food animals. As of April 2023, the market cap of Elanco is $4.7 Billion.
Do read about some of the most popular patents of Elanco which have been covered by us in this article and also you can find Elanco patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Elanco patent portfolio.
How many patents does the founder and the CEO of Elanco have?
The founder and CEO Jeffrey N. Simmons has 0 patent.
How many patents does Elanco have?
Elanco has a total of 4262 patents globally. These patents belong to 755 unique patent families. Out of 4262 patents, 2759 patents are active.
How Many Patents did Elanco File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Elanco Applications Filed||Elanco Patents Granted|
How many Elanco patents are Alive/Dead?
How Many Patents did Elanco File in Different Countries?
Countries in which Elanco Filed Patents
|United States Of America||391|
|Hong Kong (S.A.R.)||101|
|Gulf Cooperation Council||1|
Where are Research Centres of Elanco Patents Located?
10 Best Elanco Patents
US6388393B1 is the most popular patent in the Elanco portfolio. It has received 118 citations so far from companies like Merial Limited, Boehringer Ingelheim Animal Health and BASF.
Below is the list of 10 most cited patents of Elanco:
|Publication Number||Citation Count|
How many inventions of other companies were rejected due to Elanco patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Elanco invention. They couldn’t because Elanco had protected those before them.
Examiners at the USPTO referred 70 Elanco patents in 270 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Elanco patent portfolio are Bayer, Intervet and Novartis.
List of the Companies whose Patents were rejected citing Elanco –
|Company||Number of Patent Applications that faced Rejection Citing Elanco Patents||Number of Rejections (102 & 103)|
|Eli Lilly And Company||5||18|
|Dsm Ip Assets||3||3|
|Vifor Fresenius Medical Care||3||9|
Count of 102 and 103 Type Rejections based on Elanco Patents
Top Elanco Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of Elanco US Patent Applications were Granted?
Elanco (Excluding its subsidiaries) has filed 138 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 114 have been granted leading to a grant rate of 90.48%.
Below are the key stats of Elanco patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Elanco?
|Law Firm||Total Applications||Success Rate|
|Eli Lilly & Company||24||91.67%|
|Mcbee Moore & Vanik||18||92.86%|
|Barnes & Thornburg||9||100.00%|
|Hoffmann & Baron||5||0.00%|
|Eli Lilly Faegre Drinker Biddle & Reath||2||100.00%|